We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UVV icon
2801
Universal Corp
UVV
$1.18B
$396K ﹤0.01%
6,511
+558
+9% +$31.3K
DNL icon
2802
WisdomTree Global ex-U.S. Quality Growth Fund
DNL
$502M
$395K ﹤0.01%
13,746
+426
+3% +$12.1K
ACAD icon
2803
Acadia Pharmaceuticals
ACAD
$5.06B
$394K ﹤0.01%
+14,731
New +$376K
CMBM
2804
DELISTED
Cambium Networks
CMBM
$394K ﹤0.01%
+41,050
New +$394K
NXG
2805
NXG NextGen Infrastructure Income Fund
NXG
$344M
$394K ﹤0.01%
6,990
-3,260
-32% -$205K
RSPM icon
2806
Invesco S&P 500 Equal Weight Materials ETF
RSPM
$186M
$394K ﹤0.01%
+17,990
New +$381K
SAIA icon
2807
Saia
SAIA
$9.49B
$394K ﹤0.01%
6,089
-26
-0.4% -$1.66K
LFEQ icon
2808
VanEck Long/Flat Trend ETF
LFEQ
$29.2M
$393K ﹤0.01%
+14,250
New +$385K
THC icon
2809
Tenet Healthcare
THC
$20.9B
$393K ﹤0.01%
19,002
-22,075
-54% -$509K
SNLN
2810
DELISTED
Highland/iBoxx Senior Loan ETF
SNLN
$392K ﹤0.01%
22,338
+91
+0.4% +$1.61K
SWN
2811
DELISTED
Southwestern Energy Company
SWN
$391K ﹤0.01%
123,647
-39,376
-24% -$153K
RETA
2812
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$391K ﹤0.01%
+4,140
New +$357K
WIP icon
2813
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$473M
$390K ﹤0.01%
7,016
-1,000
-12% -$54K
ROG icon
2814
Rogers Corp
ROG
$2.29B
$389K ﹤0.01%
2,255
-1,310
-37% -$213K
SPWR
2815
DELISTED
SunPower Corporation Common Stock
SPWR
$389K ﹤0.01%
55,612
-19,519
-26% -$104K
CBAY
2816
DELISTED
Cymabay Therapeutics
CBAY
$389K ﹤0.01%
54,293
+2,780
+5% +$31.5K
VICR icon
2817
Vicor
VICR
$9.63B
$388K ﹤0.01%
12,500
-3,000
-19% -$96.4K
AMU
2818
DELISTED
ETRACS Alerian MLP Index ETN
AMU
$388K ﹤0.01%
24,628
-43,383
-64% -$688K
FIVN icon
2819
FIVE9
FIVN
$2.58B
$385K ﹤0.01%
7,499
-2,105
-22% -$107K
ARE icon
2820
Alexandria Real Estate Equities
ARE
$8.32B
$384K ﹤0.01%
2,724
-1,487
-35% -$215K
DWTR
2821
DELISTED
Invesco DWA Tactical Sector Rotation ETF
DWTR
$383K ﹤0.01%
12,263
+930
+8% +$28K
ROOF
2822
DELISTED
NYLI CBRE NextGen Real Estate ETF
ROOF
$381K ﹤0.01%
15,352
-40,342
-72% -$1.01M
CHUY
2823
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$381K ﹤0.01%
16,635
CVNA icon
2824
Carvana
CVNA
$81.5B
$380K ﹤0.01%
+30,335
New +$390K
PSN icon
2825
Parsons
PSN
$4.93B
$380K ﹤0.01%
+10,304
New +$338K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.